http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-930019687-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04
filingDate 1993-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1993-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-930019687-A
titleOfInvention Amino sugar derivatives
abstract The present invention relates to compounds of the general formula (I) and salts thereof.n n n n n n n n Wherein R 1 is -CO-Z 1 -N (Z 11 ) -CO-Z 2 -H or -CO-Z 3 -H, wherein Z 1 , Z 2 and Z 3 are each of 1 to 20 carbon atoms. An alkylene group, a phenylene group, or a combination thereof, and 2 may include a phenyl group or a phenylene group which may be substituted by a hydrogen atom or an alkyl group having 1 to 20 carbon atoms which may be substituted by a phenyl group. represents the number of carbon number 1 indicates an alkylene group of to 20), R 2 is -CO-Z 4 -N (Z 12 ) -CO-Z 5 -H, -CO-Z 6 -H ( wherein, Z 4 , Z 5 and Z 6 are each the same as the definition of Z 1 , Z 12 is the same as the definition of Z 11 ) or a hydrogen atom, Q 1 and Q 2 each represent a carboxyl group or a phosphonooxy group, Q 3 represents a hydrogen atom, a carboxyl group or a phosphonooxy group, m represents or an integer from 1 to 20, n represents an integer from 0 or 1 to 20, Y 1 represents -OCOR 11 and -NHCOR 12 [ Wherein R 11 is -Z 13 or -Z 7 -N (Z 14 ) -CO-Z 8 -H, where Z 7 and Z 8 are the same as defined for Z 1 , and Z 13 and Z 14 are each Is identical to the definition of Z 11 , R 12 is -Z 15 or -Z 9 -N (Z 16 ) -CO-Z 10 -H, where Z 9 and Z 10 are the same as the definition of Z 1 , and , 2 15 and 2 16 are the same as the definition of 2 11 ). &Quot; is an alkylene group having 1 to 10 carbon atoms which may include one or more substituents selected from.n n n The compounds of the present invention are useful for the treatment of multi-organ failure by inhibiting TNF induction by endotoxin.
priorityDate 1992-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393697
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456357891
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397646

Total number of triples: 21.